ATE82120T1 - Kalziumzusaetze. - Google Patents

Kalziumzusaetze.

Info

Publication number
ATE82120T1
ATE82120T1 AT88201734T AT88201734T ATE82120T1 AT E82120 T1 ATE82120 T1 AT E82120T1 AT 88201734 T AT88201734 T AT 88201734T AT 88201734 T AT88201734 T AT 88201734T AT E82120 T1 ATE82120 T1 AT E82120T1
Authority
AT
Austria
Prior art keywords
calcium
malate
calcium supplements
citrate
excipients
Prior art date
Application number
AT88201734T
Other languages
English (en)
Inventor
Stephen Allen Jacobs
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Application granted granted Critical
Publication of ATE82120T1 publication Critical patent/ATE82120T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT88201734T 1987-08-28 1988-08-15 Kalziumzusaetze. ATE82120T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9081387A 1987-08-28 1987-08-28
EP88201734A EP0304987B1 (de) 1987-08-28 1988-08-15 Kalziumzusätze

Publications (1)

Publication Number Publication Date
ATE82120T1 true ATE82120T1 (de) 1992-11-15

Family

ID=22224448

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88201734T ATE82120T1 (de) 1987-08-28 1988-08-15 Kalziumzusaetze.

Country Status (13)

Country Link
EP (1) EP0304987B1 (de)
JP (1) JP2795651B2 (de)
KR (1) KR970009583B1 (de)
AT (1) ATE82120T1 (de)
AU (1) AU625809B2 (de)
CA (1) CA1314233C (de)
DE (1) DE3875867T2 (de)
DK (1) DK481388A (de)
HK (1) HK182096A (de)
IE (1) IE61452B1 (de)
IL (1) IL87452A (de)
NZ (1) NZ225950A (de)
ZA (1) ZA886355B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2085008C (en) * 1990-06-14 1998-08-18 Mary M. Fox Calcium citrate malate composition
AU666313B2 (en) * 1991-05-06 1996-02-08 Procter & Gamble Company, The Combined calcium and vitamin D supplements
AU3240193A (en) * 1991-12-26 1993-07-28 Procter & Gamble Company, The Storage stable calcium-supplemented beverage concentrates
US5389387A (en) * 1991-12-26 1995-02-14 The Procter & Gamble Company Storage stable calcium-supplemented beverage concentrates
EP0665719B1 (de) * 1992-10-21 1997-01-15 The Procter & Gamble Company Eine konzentrierte lebensverfügbare kalziumsquelle enthaltender süssstof
WO1994008473A1 (en) * 1992-10-21 1994-04-28 The Procter & Gamble Company Storage stable calcium-supplemented beverage premix concentrates and syrups
ATE198122T1 (de) * 1992-10-21 2001-01-15 Procter & Gamble Konzentrierte, bioverfügbare kalziumquelle
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
JPH09173020A (ja) * 1995-12-28 1997-07-08 Shiro Tanaka クエン酸・リンゴ酸カルシウムの可溶性濃厚カルシウム凍結品／冷蔵品およびその製造法
JP5140669B2 (ja) * 2006-08-17 2013-02-06 ザ プロクター アンド ギャンブル カンパニー クエン酸リンゴ酸カルシウムを含む組成物及びその製造方法
US8889195B2 (en) * 2006-08-17 2014-11-18 The Procter & Gamble Company Compositions comprising calcium citrate malate and methods for making the same
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
DK2790710T3 (da) 2011-12-13 2020-11-30 Amorphical Ltd Amorft calciumcarbonat til behandling af calciummalabsorption og metaboliske knoglelidelser
JP7039006B2 (ja) 2015-06-04 2022-03-22 アモーフィカル リミテッド． 吸入、舌下又は頬側投与のための非晶質炭酸カルシウムの組成物
IL294615A (en) 2016-10-25 2022-09-01 Amorphical Ltd Amorphous calcium carbonate for the treatment of leukemia
CN112137787B (zh) * 2020-09-16 2023-01-06 张宏伟 一种足踝外科下胫腓关节复位固定导向器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697248A (en) * 1979-12-28 1981-08-05 Tanaka Shiro Conjugated compound of calcium citrate and calcium malate and its preparation
FR2601249A1 (fr) * 1986-07-09 1988-01-15 Sandoz Lab Nouvelles compositions pharmaceutiques a base de sels de calcium.
US4786510A (en) * 1987-07-02 1988-11-22 The Procter & Gamble Company Calcium-iron mineral supplements
CA1319612C (en) * 1987-07-02 1993-06-29 Haile Mehansho Iron-calcium mineral supplements with enhanced bioavailability

Also Published As

Publication number Publication date
DK481388A (da) 1989-03-02
HK182096A (en) 1996-10-11
CA1314233C (en) 1993-03-09
JPH01156985A (ja) 1989-06-20
IL87452A0 (en) 1989-01-31
EP0304987A2 (de) 1989-03-01
JP2795651B2 (ja) 1998-09-10
AU2159888A (en) 1989-06-15
IE882610L (en) 1989-02-28
EP0304987A3 (en) 1990-02-21
IE61452B1 (en) 1994-11-02
EP0304987B1 (de) 1992-11-11
DE3875867T2 (de) 1993-04-01
DK481388D0 (da) 1988-08-29
ZA886355B (en) 1989-05-30
KR970009583B1 (en) 1997-06-14
DE3875867D1 (de) 1992-12-17
IL87452A (en) 1992-07-15
KR890003391A (ko) 1989-04-14
AU625809B2 (en) 1992-07-16
NZ225950A (en) 1991-10-25

Similar Documents

Publication Publication Date Title
ATE82120T1 (de) Kalziumzusaetze.
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
IL84425A (en) (s) - (+) -ibuprofen-containing pharmaceutical compositions
IL83510A0 (en) Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or salts thereof and their preparation
GB2259647B (en) Medicaments for treating gastrointestinal disorders
SE9002500D0 (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
DK0389035T3 (da) Farmaceutisk præparat der indeholder en farmaceutisk egnet bærer og forbindelsen med strukturen (7alfa,17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on
PH25585A (en) Method for the treatment of osteoporosis, related disorders
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
DE3766885D1 (en) Chlorpheniramine therapie.
IT1224250B (it) Associzione del depiprazolo con la morfina
EP0316709A3 (en) Proteinaceous derivatives containing iron in highly bioaproteinaceous derivatives containing iron in highly bioavailable form, preparation thereof and pharmaceutical covailable form, preparation thereof and pharmaceutical compositions containing them mpositions containing them
DE3786168D1 (de) Verwendung von para-aminobenzoesaeure zur herstellung eines arzneimittels zur bekaempfung von photoallergien.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time